Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Total Current Liabilities (2018 - 2026)

Bicycle Therapeutics (BCYC) has disclosed Total Current Liabilities for 9 consecutive years, with $48.9 million as the latest value for Q1 2026.

  • For Q1 2026, Total Current Liabilities fell 15.16% year-over-year to $48.9 million; the TTM value through Mar 2026 reached $48.9 million, down 15.16%, while the annual FY2025 figure was $57.0 million, 15.24% down from the prior year.
  • Total Current Liabilities hit $48.9 million in Q1 2026 for Bicycle Therapeutics, down from $57.0 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $77.4 million in Q2 2025 and bottomed at $35.4 million in Q1 2022.
  • Average Total Current Liabilities over 5 years is $58.2 million, with a median of $57.0 million recorded in 2025.
  • Year-over-year, Total Current Liabilities soared 77.64% in 2022 and then fell 19.12% in 2024.
  • Bicycle Therapeutics' Total Current Liabilities stood at $53.3 million in 2022, then skyrocketed by 30.36% to $69.5 million in 2023, then fell by 3.32% to $67.2 million in 2024, then decreased by 15.24% to $57.0 million in 2025, then fell by 14.21% to $48.9 million in 2026.
  • According to Business Quant data, Total Current Liabilities over the past three periods came in at $48.9 million, $57.0 million, and $69.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.